Crystal structure of PBP2x from a highly penicillin-resistant Streptococcus pneumoniae clinical isolate: a mosaic

A Dessen1, N Mouz, E Gordon

  • 1Laboratoire de Cristallographie Macromoléculaire, Institut de Biologie Structurale Jean-Pierre Ebel (CNRS/Commissariat à l'Energie Atomique), 41, rue Jules Horowitz, 38027 Grenoble, France. dessen@ibs.fr

Insights

Penicillin-binding proteins (PBPs) are key targets for beta-lactam antibiotics. Mutations in Streptococcus pneumoniae PBP2x create an "open" active site, facilitating resistance by altering substrate recognition.

Area of Science:

  • Microbiology
  • Structural Biology
  • Biochemistry

Background:

  • Penicillin-binding proteins (PBPs) are crucial targets for beta-lactam antibiotics in bacteria.
  • Antibiotic resistance, particularly in Gram-positive bacteria like Streptococcus pneumoniae, often arises from modifications in PBP genes.
  • PBP2x is a key protein conferring high-level resistance to beta-lactams in S. pneumoniae.

Purpose of the Study:

  • To elucidate the atomic-level mechanisms of beta-lactam resistance in Streptococcus pneumoniae.
  • To understand how mutations in PBP2x contribute to penicillin resistance.

Main Methods:

  • X-ray crystallography was used to determine the structure of PBP2x from a resistant S. pneumoniae isolate (Sp328).
  • Analysis of mutations within the PBP2x active site and their impact on protein structure and function.

Main Results:

  • The crystal structure of Sp328 PBP2x, containing 83 mutations, was solved.
  • Specific mutations (Thr338Ala, Ser389Leu, Asn514His) were identified near the active site.
  • These mutations weaken hydrogen bonds, displace a key water molecule, and create a more "open" active site conformation.

Conclusions:

  • The structural alterations in PBP2x lead to an "open" active site.
  • This open conformation may allow the enzyme to bind and process abnormal, branched peptidoglycan substrates characteristic of resistant strains.
  • Understanding these structural changes is vital for developing new strategies against beta-lactam-resistant bacteria.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...